Nantahala Capital Management, LLC Neuro Pace Inc Transaction History

Nantahala Capital Management, LLC

$2.29 Billion
Q2 2025

A detailed history of Nantahala Capital Management, LLC transactions in Neuro Pace Inc stock. As of the latest transaction made, Nantahala Capital Management, LLC holds 295,089 shares of NPCE stock, worth $2.69 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares

295,089

Previous 312,094 5.45%

Holding current value

$2.69 Million

Previous $3.84 Million 14.29%

% of portfolio

0.14%

Previous 0.17%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$10.34 - $18.13 $175,831 - $308,300	-17,005 Reduced 5.45%	295,089 $3.29 Million
Q1 2025 May 15, 2025	SELL	$10.04 - $14.94 $2.51 Million - $3.73 Million	-249,979 Reduced 44.47%	312,094 $3.84 Million
Q4 2024 Feb 14, 2025	SELL	$5.9 - $11.93 $270,320 - $546,596	-45,817 Reduced 7.54%	562,073 $6.29 Million
Q3 2024 Nov 14, 2024	SELL	$6.65 - $8.46 $59,404 - $75,573	-8,933 Reduced 1.45%	607,890 $4.24 Million
Q2 2024 Aug 14, 2024	SELL	$6.38 - $15.33 $1.03 Million - $2.47 Million	-161,437 Reduced 20.74%	616,823 $4.66 Million
Q1 2024 May 15, 2024	SELL	$9.78 - $17.5 $3.87 Million - $6.92 Million	-395,417 Reduced 33.69%	778,260 $10.3 Million
Q4 2023 Feb 14, 2024	SELL	$5.9 - $10.31 $272,804 - $476,713	-46,238 Reduced 3.79%	1,173,677 $12.1 Million
Q3 2023 Nov 14, 2023	BUY	$4.0 - $9.73 $3.18 Million - $7.74 Million	795,065 Added 187.14%	1,219,915 $11.9 Million
Q2 2023 Aug 14, 2023	SELL	$3.98 - $5.12 $4,278 - $5,504	-1,075 Reduced 0.25%	424,850 $1.91 Million
Q1 2023 May 15, 2023	SELL	$1.44 - $5.34 $11,026 - $40,888	-7,657 Reduced 1.77%	425,925 $1.98 Million
Q4 2022 Feb 14, 2023	SELL	$1.29 - $3.67 $12,796 - $36,406	-9,920 Reduced 2.24%	433,582 $646,000
Q3 2022 Nov 10, 2022	SELL	$3.1 - $5.98 $108,301 - $208,917	-34,936 Reduced 7.3%	443,502 $1.66 Million
Q2 2022 Aug 15, 2022	SELL	$4.95 - $8.7 $33,981 - $59,725	-6,865 Reduced 1.41%	478,438 $2.37 Million
Q1 2022 May 13, 2022	BUY	$7.06 - $11.57 $1.27 Million - $2.08 Million	179,397 Added 58.64%	485,303 $3.98 Million
Q4 2021 Feb 14, 2022	BUY	$8.63 - $17.36 $1.42 Million - $2.85 Million	164,265 Added 115.97%	305,906 $3.08 Million
Q3 2021 Nov 15, 2021	SELL	$15.85 - $25.07 $91,343 - $144,478	-5,763 Reduced 3.91%	141,641 $2.25 Million
Q2 2021 Aug 16, 2021	BUY	$19.03 - $26.5 $2.81 Million - $3.91 Million	147,404 New	147,404 $3.51 Million

Others Institutions Holding NPCE

# of Institutions

108

Shares Held

21.4M

Call Options Held

3.14M

Put Options Held

68.6K

View Full List

About NeuroPace Inc

Ticker NPCE
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,846,900
Market Cap $227M
Description
NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and ena...

More about NPCE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nantahala Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nantahala Capital Management, LLC with notifications on news.

Account

Nantahala Capital Management, LLC Neuro Pace Inc Transaction History